a clinical publisher network × Adverge, 31-day head-to-head
+62% revenue.
+43% CPM.
Same inventory.
A healthcare publisher running clinical properties read largely by practicing providers ran Adverge against its incumbent monetization platform for a full month. Revenue rose 62% and CPM rose 43%. The mechanism was not a bidding trick. The Adverge wrapper carried the publisher’s first-party data and provider-level credentials into the bid request, so endemic healthcare demand could finally see what it was buying, and bid against itself for it.
Revenue
+62%
vs. the incumbent platform
CPM
+43%
$0.92 → $1.32
Test length
31 days
one full calendar month
Incumbent platform
$0.92
CPM across the test month
Adverge
$1.32
CPM on the same properties, same traffic, same calendar month. The only variable changed was the monetization layer.
Live on Yield Cortex, ongoing →
01 Executive Summary
The price went up, and so did the volume.
The usual way to raise CPM is to sell less. Floors go up, fill goes down, and the average improves against a smaller base. That is a reporting win, not a revenue win, and publishers have learned to distrust it.
This test moved both. Revenue rose 62%. Price per thousand rose 43%. Revenue outran price, which means volume grew too: more demand matched to the same visits, sold at a better rate rather than a worse one. Nothing was withheld to manufacture the average.
Incumbent platform
Axis values are deliberately omitted. The shape is the point: the Adverge bar clears the incumbent on 22 of the 31 days, and the gap widens on the high-value days rather than narrowing.
The daily view matters for confidence. This is not one good week carrying a month. The Adverge bar clears the incumbent on 22 of the 31 days, and the gap is widest on the days when inventory was worth the most, which is exactly when a monetization layer earns its keep.
02 The Test
One month. One variable.
The publisher runs clinical reference and professional-education properties. The audience is unusually specific: a large share are practicing clinicians reading in a professional context rather than consumers browsing health content. That audience is worth a great deal to the right buyer and almost nothing to a generic one.
Both platforms ran across a full calendar month on the same properties and the same traffic. No redesign, no new ad units mid-flight, no editorial change. The monetization layer was the only thing that differed.
Figures are the publisher’s own reported totals for the test month, taken from the reconciliation the publisher and Adverge ran together. The publisher and the incumbent platform are not named at the publisher’s request, and absolute revenue and volume figures are withheld for the same reason.
03 What The Wrapper Carries
Endemic demand cannot buy what it cannot see.
Endemic healthcare demand does not buy pages. It buys verified professional audiences: a cardiologist, an OB-GYN, a specific specialty in a specific setting. Pharmaceutical and clinical advertisers are bound by what they can prove about who saw the message, so their buying platforms are built to target on provider identity and to withhold their budget when identity cannot be established.
This is where most wrappers quietly lose the money. They pass a generic bid request: a URL, a size, a device, an anonymous cookie. To an endemic DSP that request is unreadable. It cannot confirm a provider is on the other side, so it either does not bid at all or bids at the same rate it would pay for any anonymous health-adjacent reader. The publisher’s most valuable characteristic, the thing that makes the audience worth a premium, never reaches the auction.
The Adverge wrapper absorbs the publisher’s first-party data at the session layer and carries it, alongside provider-level credentials including NPI-derived signals, into the bid request itself. The endemic buyer receives a request it can actually evaluate: a professional audience it can verify against its own targeting, in a context it understands.
NPI is a public professional credential, not patient data. The National Provider Identifier identifies a clinician in their professional capacity, in the same register a medical license sits in. Nothing in this setup involves patient information, health records or diagnosis data. The signal describes a professional audience, not a person’s health.
The effect on the auction is mechanical. One buyer able to identify the audience will pay more than a buyer who cannot. Several buyers able to identify the same audience have to outbid each other, and the clearing price is set by the second-highest bid rather than by a floor. Endemic partners that had been dormant under the incumbent came back in and competed, and competition is what moved the CPM 43%.
- First-party data absorbed at the wrapper. Session context is collected once and made available to every request in the visit, rather than rebuilt per impression.
- Provider credentials travel with the request. NPI-derived professional signals reach the endemic buyer in the bid request, not in a post-campaign report.
- Endemic partners compete rather than abstain. Multiple qualified bidders on the same impression set the price between them.
04 Why Revenue Per Session
A visit arrives carrying signal.
A user does not arrive as an impression. They arrive as a session, and a session carries intent, history and professional context. That is the most valuable thing the publisher owns, and it exists for the length of the visit.
An impression-level stack discards it and prices each slot as though it were anonymous. A session-level stack keeps it, so every request after the first is better informed than the one before. On a clinical property the difference is stark, because the single fact that matters most, who this reader is professionally, is established early in the visit and is useful for every impression that follows.
Adverge runs this through Yield Cortex, the publisher-side monetization layer, with Data Cortex supplying the identity and affinity signals underneath it. Wrapper logic, demand orchestration, floor pricing and session-level signal sit on one control plane, so a decision made on the first request in a visit is available to every request after it.
05 Endemic & Non-Endemic
Two demand pools. Both moved.
Health inventory has two buyers that behave nothing alike. Endemic demand is the specialist pool buying against specialty, credential and professional audience. It clears at CPMs one to two orders of magnitude above the page average, in the tens of dollars per thousand rather than fractions of a dollar, and it is thin: small volumes bought on tight targeting. Non-endemic demand is general programmatic buying the same page for reach, deep and always available, priced like a commodity.
The endemic lift is the headline, but the non-endemic result is the one that should not have happened. Adverge raised the non-endemic CPM 25% at the same time. Ordinarily, pulling high-CPM endemic demand into an auction cannibalizes the commodity pool underneath it: the good impressions get taken and the rest clear cheaper. Here the floor rose with the ceiling.
The reason is the same signal. A request that tells an endemic buyer this is a verified professional audience also tells a general buyer this is a real, engaged, identifiable human being rather than an anonymous impression. Both pools reprice on the same information.
06 The Results
+62% revenue. On a higher price, not a smaller base.
Revenue, Adverge vs. the incumbent platform
+62%
Across the test month. Same properties, same traffic, monetization layer swapped.
CPM
+43%
$0.92 → $1.32, achieved while volume grew rather than shrank.
| Measure | Incumbent platform | Adverge | Change |
|---|---|---|---|
| Revenue | Baseline | Higher | +62.2% |
| CPM | $0.92 | $1.32 | +43.0% |
| Provider signal in bid request | Absent | Carried | Added |
The revenue line is the outcome. The CPM line is the explanation, and the reason the CPM moved is that the auction finally contained buyers who could tell what they were bidding on.
07 Conclusion
The audience was always worth this much.
Nothing about the publisher’s audience changed during this test. The same clinicians read the same articles in the same month. What changed is that the buyers who value that audience most could finally identify it at the moment of the auction, and were willing to pay accordingly.
That is the practical argument for treating the wrapper as a data layer rather than as plumbing. A wrapper that only routes requests will always leave endemic money on the table, because the request it sends is unreadable to the buyer who would pay the most for it. A wrapper that carries first-party data and provider credentials turns a generic impression into an identifiable one, and identifiable inventory is worth more to everybody bidding on it.
For publishers with a professional or clinical audience, this is where the largest unclaimed revenue sits. The more specific your readership, the more you lose on every request that goes out without saying who they are.
Work with Adverge
Run the same test on your inventory.
Adverge runs head-to-head tests against an incumbent on live traffic, measured on revenue per session rather than impression counts. If your audience is worth more to advertisers than your CPM suggests, a month of side-by-side data will show it.